MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/circulationaha.124.070535

Медицинская библиотека · Circulation · 2024

Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach.

Chew Nicholas W S, Mehta Anurag, Goh Rachel Sze Jen, Zhang Audrey, Chen Yiming, Chong Bryan, Chew Han Shi Jocelyn, Shabbir Asim, Brown Adrian, Dimitriadis Georgios K, Huang Daniel Q, Foo Roger, le Roux Carel W, Figtree Gemma A, Fudim Marat, Pandey Ambarish, Mamas Mamas A, Hausenloy Derek J, Richards A Mark, Nicholls Stephen J, Chan Mark Y, Muthiah Mark D, Sanyal Arun, Sperling Laurence S

СтатьяОбзорПеревод пока не подготовлен

Аннотация

There is a new awareness of the widespread nature of metabolic dysfunction-associated steatotic liver disease (MASLD) and its connection to cardiovascular disease (CVD). This has catalyzed collaboration between cardiologists, hepatologists, endocrinologists, and the wider multidisciplinary team to address the need for earlier identification of those with MASLD who are at increased risk for CVD. The overlap in the pathophysiologic processes and parallel prevalence of CVD, metabolic syndrome, and MASLD highlight the multisystem consequences of poor cardiovascular-liver-metabolic health. Metabolic dysfunction and associated insulin resistance, together with the predilection for ectopic fat deposition in the liver and surrounding tissues, are associated with elevated risk of endothelial dysfunction, systemic inflammatory response, and ectopic fat deposition in the epicardium. This complex pathophysiology can accelerate atherogenic dyslipidemia, atherogenesis, diastolic dysfunction, valvular calcification, and cardiac arrhythmias. Despite the mounting evidence of mechanistic pathways underpinning MASLD and CVD, current recommendations have not clearly focused upon MASLD as a risk factor or target for intervention in CVD. We have brought together a diverse range of international experts committed to promoting cardiovascular-liver-metabolic health and related outcomes across the globe. The overarching goal of this document is to offer a construct for clinicians in the cardiovascular field with regards to (1) diagnosis and screening of MASLD through the use of noninvasive serum and imaging tests; (2) screening for CVD in all individuals with MASLD regardless of established atherosclerotic risk factors; and (3) the approach to management of MASLD with respect to prevention of CVD through lifestyle, as well as pharmacologic and surgical strategies. To achieve this, the modified Delphi method was applied and a series of evidence-based quality standard recommendations have been identified.

Для цитирования: Chew Nicholas W S, Mehta Anurag, Goh Rachel Sze Jen, Zhang Audrey, Chen Yiming, Chong Bryan, Chew Han Shi Jocelyn, Shabbir Asim, Brown Adrian, Dimitriadis Georgios K, Huang Daniel Q, Foo Roger, le Roux Carel W, Figtree Gemma A, Fudim Marat, Pandey Ambarish, Mamas Mamas A, Hausenloy Derek J, Richards A Mark, Nicholls Stephen J, Chan Mark Y, Muthiah Mark D, Sanyal Arun, Sperling Laurence S. Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach.. Circulation. 2024. DOI: 10.1161/circulationaha.124.070535.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.